HLN healthscope notes limited

Last year the company failed an attempt to sell its pathology...

  1. chris_qld
    242 Posts.
    clock Created with Sketch.
    11/03/13
    16:20
    Post #: 11523442
    Last year the company failed an attempt to sell its pathology business to raise $100 million. At the same time,it suffered heavy losses. Now they want to issue new subordinated notes. Does it ring the bell?
    HLN Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
1CG OneClick surpasses 150,000 registered users
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
watchlist Created with Sketch. Add HLN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.